Phase III placebo-controlled, double-blind, randomized trial of pegfilgrastim to reduce the risk of febrile neutropenia in breast cancer patients receiving docetaxel/cyclophosphamide chemotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-7339
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Phase III placebo-controlled, double-blind, randomized trial of pegfilgrastim to reduce the risk of febrile neutropenia in breast cancer patients receiving docetaxel/cyclophosphamide chemotherapy ; volume:23 ; number:4 ; day:10 ; month:1 ; year:2015 ; pages:1137-1143 ; date:4.2015
Supportive care in cancer ; 23, Heft 4 (10.1.2015), 1137-1143, 4.2015
- Creator
-
Kosaka, Yoshimasa
Rai, Yoshiaki
Masuda, Norikazu
Takano, Toshimi
Saeki, Toshiaki
Nakamura, Seigo
Shimazaki, Ryutaro
Ito, Yoshinori
Tokuda, Yutaka
Tamura, Kazuo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00520-014-2597-1
- URN
-
urn:nbn:de:101:1-2019080319084218163259
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kosaka, Yoshimasa
- Rai, Yoshiaki
- Masuda, Norikazu
- Takano, Toshimi
- Saeki, Toshiaki
- Nakamura, Seigo
- Shimazaki, Ryutaro
- Ito, Yoshinori
- Tokuda, Yutaka
- Tamura, Kazuo
- SpringerLink (Online service)
Other Objects (12)
Febrile neutropenia : with 32 tables
Chemotherapy and febrile neutropenia - diagnostic and therapeutic management
Antimicrobial stewardship in high-risk febrile neutropenia patients
Prophylactic pegfilgrastim reduces febrile neutropenia in ramucirumab plus docetaxel after chemoimmunotherapy in advanced NSCLC: post hoc analysis from NEJ051
Assessment of Chemotherapy-Induced Febrile Neutropenia in Cancer Patients
Diagnostics and therapy of paediatric patients with febrile neutropenia
Bacterial infection profiles in lung cancer patients with febrile neutropenia
Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
Pegfilgrastim for primary prophylaxis of febrile neutropenia in multiple myeloma
Time to antibiotics and outcomes in cancer patients with febrile neutropenia
Epedimiologic, clinical profile and factors affecting the outcome in febrile neutropenia
Oral Antibiotic Therapy for Low Risk Febrile Neutropenia: Time to Dare
Febrile neutropenia : with 32 tables
Chemotherapy and febrile neutropenia - diagnostic and therapeutic management
Antimicrobial stewardship in high-risk febrile neutropenia patients
Prophylactic pegfilgrastim reduces febrile neutropenia in ramucirumab plus docetaxel after chemoimmunotherapy in advanced NSCLC: post hoc analysis from NEJ051
Assessment of Chemotherapy-Induced Febrile Neutropenia in Cancer Patients
Diagnostics and therapy of paediatric patients with febrile neutropenia
Bacterial infection profiles in lung cancer patients with febrile neutropenia
Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
Pegfilgrastim for primary prophylaxis of febrile neutropenia in multiple myeloma
Time to antibiotics and outcomes in cancer patients with febrile neutropenia
Epedimiologic, clinical profile and factors affecting the outcome in febrile neutropenia
Oral Antibiotic Therapy for Low Risk Febrile Neutropenia: Time to Dare
Febrile neutropenia : with 32 tables
Chemotherapy and febrile neutropenia - diagnostic and therapeutic management
Antimicrobial stewardship in high-risk febrile neutropenia patients
Prophylactic pegfilgrastim reduces febrile neutropenia in ramucirumab plus docetaxel after chemoimmunotherapy in advanced NSCLC: post hoc analysis from NEJ051
Assessment of Chemotherapy-Induced Febrile Neutropenia in Cancer Patients
Diagnostics and therapy of paediatric patients with febrile neutropenia
Bacterial infection profiles in lung cancer patients with febrile neutropenia
Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
Pegfilgrastim for primary prophylaxis of febrile neutropenia in multiple myeloma
Time to antibiotics and outcomes in cancer patients with febrile neutropenia
Epedimiologic, clinical profile and factors affecting the outcome in febrile neutropenia